Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism
2012 ◽
Vol 131
(11)
◽
pp. 2693-2703
◽
Keyword(s):
Aurora A
◽